Adenovirus-Mediated Factor VIII Gene Expression Results in Attenuated Anti-Factor VIII-Specific Immunity in Hemophilia A Mice Compared with Factor VIII Protein Infusion-Reference-Cited by-同舟云学术

Adenovirus-Mediated Factor VIII Gene Expression Results in Attenuated Anti-Factor VIII-Specific Immunity in Hemophilia A Mice Compared with Factor VIII Protein Infusion

Published:2001-09 Issue:13 Volume:12 Page:1651-1661
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Bristol J. Andrew¹,Gallo-Penn Angela¹,Andrews Julie¹,Idamakanti Neeraja¹,Kaleko Michael¹,Connelly Sheila¹

Affiliation:

1. DNA Viral Vectors Unit, Genetic Therapy, Inc., A Novartis Company, Gaithersburg, MD 20878.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430340152528147

Reference56 articles.

1. Production and Characterization of Improved Adenovirus Vectors with the E1, E2b, and E3 Genes Deleted

2. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A

3. German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies

4. In Vivo Dose Threshold Effect of Adenovirus-Mediated Factor VIII Gene Therapy in Hemophiliac Mice

5. The Canine Factor VIII cDNA and 5’ Flanking Sequence

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Immunogenicity of Protein Drugs by ApplyingIn VitroMHC Binding Data and the Immune Epitope Database and Analysis Resource;Clinical and Developmental Immunology;2013

2. Gene therapy for hemophilia A. Friend or foe?;Blood Coagulation & Fibrinolysis;2009-09

3. The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy;Biotechnology Letters;2008-11-02

4. Overcoming the immunologic response to foreign enzymes in cancer therapy;Expert Review of Clinical Immunology;2005-11

5. Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy;Proceedings of the National Academy of Sciences;2005-04-18